JPMorgan Chase & Co. Reiterates “€74.00” Price Target for Gerresheimer (GXI)

JPMorgan Chase & Co. set a €74.00 ($91.36) target price on Gerresheimer (ETR:GXI) in a report issued on Tuesday morning. The firm currently has a neutral rating on the stock.

GXI has been the topic of a number of other reports. Credit Suisse Group set a €75.00 ($92.59) price target on Gerresheimer and gave the company a buy rating in a research report on Wednesday, February 21st. DZ Bank reiterated a buy rating on shares of Gerresheimer in a research report on Monday, February 26th. Deutsche Bank set a €64.00 ($79.01) price target on Gerresheimer and gave the company a neutral rating in a research report on Friday, December 1st. Hauck & Aufhaeuser set a €55.00 ($67.90) price target on Gerresheimer and gave the company a sell rating in a research report on Wednesday, January 24th. Finally, equinet set a €75.00 ($92.59) price target on Gerresheimer and gave the company a neutral rating in a research report on Friday, January 19th. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and four have issued a buy rating to the company. The company currently has an average rating of Hold and a consensus target price of €69.64 ($85.97).

How to Become a New Pot Stock Millionaire

Shares of Gerresheimer (ETR GXI) opened at €66.20 ($81.73) on Tuesday. Gerresheimer has a 1 year low of €59.97 ($74.04) and a 1 year high of €78.25 ($96.60). The firm has a market capitalization of $2,100.00 and a price-to-earnings ratio of 20.62.

ILLEGAL ACTIVITY WARNING: “JPMorgan Chase & Co. Reiterates “€74.00” Price Target for Gerresheimer (GXI)” was originally reported by Transcript Daily and is the sole property of of Transcript Daily. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The correct version of this story can be accessed at https://transcriptdaily.com/2018/03/21/jpmorgan-chase-74-00-price-target-for-gerresheimer-gxi.html.

About Gerresheimer

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply